Billiontoone, Inc. (NASDAQ:BLLN) Stock Has Average Target Price of $126.25 According to Analysts

Shares of Billiontoone, Inc. (NASDAQ:BLLN) have received an average recommendation of “Moderate Buy” from the eleven brokerages that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year target price among analysts that have covered the stock in the last year is $126.25.

A number of research analysts have recently issued reports on the company. Canaccord Genuity Group initiated coverage on Billiontoone in a research report on Wednesday, September 2nd. They set a “buy” rating and a $120.00 target price on the stock. Guggenheim boosted their price target on shares of Billiontoone from $125.00 to $128.00 and gave the stock a “buy” rating in a report on Thursday, October 1st. Weiss Ratings lowered shares of Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a report on Thursday, October 8th. Wall Street Zen cut shares of Billiontoone from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Finally, Zacks Research raised shares of Billiontoone from a “strong sell” rating to a “hold” rating in a report on Friday, October 2nd.

Insider Buying and Selling

In related news, insider Thomas Lynch sold 35,112 shares of the firm’s stock in a transaction dated Thursday, September 17th. The shares were sold at an average price of $110.33, for a total value of $3,873,906.96. Following the transaction, the insider directly owned 700 shares of the company’s stock, valued at approximately $77,231. This trade represents a 98.05% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 32,500 shares of the firm’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $136.95, for a total value of $4,450,875.00. Following the completion of the transaction, the chief executive officer owned 20,000 shares in the company, valued at approximately $2,739,000. This trade represents a 61.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 249,025 shares of company stock worth $27,387,892 in the last 90 days. Insiders own 50.22% of the company’s stock.

Institutional Investors Weigh In On Billiontoone

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Integrated Wealth Concepts LLC acquired a new position in Billiontoone in the second quarter valued at approximately $29,000. Toth Financial Advisory Corp grew its position in Billiontoone by 60.0% in the third quarter. Toth Financial Advisory Corp now owns 800 shares of the company’s stock worth $85,000 after acquiring an additional 300 shares during the period. MCF Advisors LLC grew its position in Billiontoone by 330.8% in the second quarter. MCF Advisors LLC now owns 448 shares of the company’s stock worth $54,000 after acquiring an additional 344 shares during the period. Family Legacy Financial Solutions LLC purchased a new position in Billiontoone in the third quarter worth approximately $53,000. Finally, Thrive Wealth Management LLC acquired a new stake in Billiontoone during the second quarter worth $240,000.

Billiontoone Trading Up 1.1%

NASDAQ BLLN opened at $104.67 on Thursday. The company has a market capitalization of $4.94 billion and a PE ratio of 149.53. The company has a fifty day moving average of $101.30 and a 200 day moving average of $102.28. Billiontoone has a 1 year low of $61.96 and a 1 year high of $150.44. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.15. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. The company had revenue of $109.45 million during the quarter. Research analysts forecast that Billiontoone will post 0.80 earnings per share for the current year.

Billiontoone Company Profile

BillionToOne, Inc is a molecular diagnostics company that develops tests designed to provide more sensitive and quantitative genetic information from blood samples. The company’s technology is based on its proprietary Quantitative Counting Template (QCT) platform, which is designed to measure DNA molecules with high sensitivity and support the detection of clinically meaningful genetic signals.

The company’s products include prenatal diagnostic and screening solutions marketed under the UNITY brand.